The Antibody Society

the official website of the antibody society

An international non-profit supporting antibody-related research and development.

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Board of Directors
    • Our Staff & Volunteers
    • The Antibody Society’s Standing Committees
      • AIRR Community Committee
      • Communication & Membership Committee
      • Executive Committee
      • Finance & Audit Committee
      • Governance & Nominating Committee
      • Initiatives Committee
      • Meetings Committee
    • Sponsors & Partners
  • Society meetings
    • Biopharmaceutical Informatics Symposium
    • Harnessing Cytokines for Cancer Immunotherapy Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2022
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 2022
    • FOCIS Symposia
  • AIRR Community
    • AIRR News
    • AIRR Publications
    • AIRR Meetings
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-committees
      • Communications Sub-committee
      • Executive Sub-committee
      • Inferred Allele Review Committee
      • Meetings Sub-committee
    • AIRR Data Commons
    • AIRR Community Calendar
    • AIRR Community Webinar Series
    • On AIRR – An AIRR Community Podcast
    • AIRR Community Resources
    • AIRR Community Service Prize 2022
  • Members only
    • Login
    • Note to members
    • James S. Huston Antibody Science Talent Award
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • JSH Award Criteria
    • Research Competitions
    • Science Writing Competition
      • Science Writing Competition Winners
    • Discount codes for meeting registration
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars
    • Adaptive Immune Receptor Repertoires
    • Antibody Discovery & Development
    • Commercializing Antibody Therapeutics
    • Antibodies to Watch
    • Antibody Validation
  • COVID-19
    • Guide to “Coronavirus in the Crosshairs”
    • COVID-19 Biologics Tracker
    • Meeting Report: The Diagnostic Landscape for COVID-19
You are here: Home / Career Shorts

Career Shorts

 

The Antibody Society is proud to present Career Shorts.

In this series, we talk to scientists and individuals working within the world of antibodies about the experiences that have shaped their careers and have got them to where they are today. By sharing their experiences and advice we aim to empower the next generation of scientists and leaders working in this field and beyond to make confident and empowered decisions in the next steps in their careers.

We broach topics that range from their journey so far in science to understanding the role they play in their organisation to action that those undertaking a PhD or a post-doc can take now to make smooth their transitions into their next position in whatever shape that may take.

We hope this series will be insightful, interesting, and valuable to those seeking reassurance and understanding about the various career options available to them after their degrees or helping them to make transitions from an early career position. Most importantly, to see how there are many different paths to various career options and to feel empowered in their journey.

Your host

Raquel Barroso Ferro

Raquel Barroso Ferro is the creator and host of Career Shorts. She is a volunteer for the Education and Career Sub-Committee, and a PhD student at the University of Aberdeen, UK, currently working to develop a novel scFv-based immunotherapy against ovarian cancer.

Curious about the possibilities after a PhD and what they entail, with the help of Janice Reichert (Executive Director, The Antibody Society), reached out to the Antibody Society community to speak to them about their career trajectories so far and what advice they can give to students and people starting out in their careers. This series hopes to make some steps forward in demystifying the exciting possibilities available and give confidence that each person can find an opportunity that caters to their strengths and desires.

This work couldn’t have been done without the support and help of the rest of the Antibody Society communications committee: Dr Janice Reichert, Dr Nick Hutchinson, Dr Alicia Chenowith, Dr Silvia Screscioli, Dr Simone Richardson, and Dr. Vaishali Kapoor.

LinkedIn: www.linkedin.com/in/raquel-ferro

Our interviewees

Ep 1: Dr. Li Zhou

Li ZhouLi Zhou is a principal scientist at AbbVie operation S &T Protein Analytics and an assistant editor of mAbs. At Abbvie, he works on all aspects of biologics analytical development from R and D transition to commercial launch. Prior to this role, he has five years of experience working on over 70 drug discovery projects spanning immunology, oncology, neuroscience and virology and has served as biologics lead with external partners for co-developing conditional biologics. Li obtained his PhD in chemistry with professor Adrian Whitty at Boston University and regulatory affair certification in US. Since joining AbbVie in 2015, he has authored 8 peer-reviewed publications (4 as lead author) including JBC, mAbs, analytical chemistry.

LinkedIn profile: www.linkedin.com/in/li-zhou-8a179a55

Career Shorts Ep 1 – Full episode: https://www.youtube.com/watch?v=Y9xtGRLQaSM


Ep 2: Dr. Nimish Gera

Nimish Gera - Crunchbase Person Profile

Nimish is an accomplished leader with over a decade of experience in the biotech industry and broad expertise across various modalities (monoclonal antibodies, bispecific antibodies, protein-fusions, and antibody-drug conjugates (ADCs)) and therapeutic areas (oncology, immuno-oncology, autoimmune and rare diseases). Nimish has extensive experience building, and leading high performing discovery and development teams and managing external collaborations in matrixed industry settings. He has a successful track record of several peer-reviewed publications, patents and chairing national and international meetings on antibody discovery and engineering. In October 2017, Nimish joined Mythic Therapeutics as the Scientific Co-Founder and Director of Research and Development and now serves as the Head of Biologics where he leads a team involved in antibody discovery, engineering and optimization and cell-based screening technologies.

Prior to Mythic, Nimish was a Research Scientist at Alexion Pharmaceuticals where he led and managed diverse cross-functional project teams of 10+ scientists to lead two antibody discovery programs into development.  Prior to Alexion, Nimish helped set up the Discovery Sciences function at Oncobiologics (now Outlook Therapeutics) and identified multiple lead candidates for the company’s platform. Nimish earned a PhD in Chemical and Biomolecular Engineering from North Carolina State University with a minor in Biotechnology. He also serves as an Assistant Editor for the mAbs journal and has reviewed 50+ high impact articles in antibody discovery and engineering. Nimish is extremely passionate about people management, mentoring and process optimization to accelerate drug development and has a keen interest in teaching, coaching, and mentoring young scientists.

Career Shorts Ep 2 – Full episode: [https://youtu.be/kOpuBxNdS5A]


Ep 3: Professor Charlotte Deane

Charlotte Deane - Wikipedia

Professor Charlotte Deane (http://www.stats.ox.ac.uk/~deane/) leads the Oxford Protein Informatics group, a research group of over 25 people working on diverse problems across protein structure, immunoinformatics, interaction networks and small molecule drug discovery. She is also Deputy Executive Chair of the Engineering and Physical Sciences and Council and the Covid-19 Response Director for UK Research and Innovation.

Twitter: @OPIGlets

Group website: OPIG (ox.ac.uk)

Career Shorts Ep 3 – Full episode: [Release date 25th October 2021]


Ep 4: Dr Feng Yang

Feng YANG | Genentech, California

Feng received her Ph.D. and postdoctoral training in two prominent biological mass spectrometry and proteomics labs, led by Prof. Donald F. Hunt at University of Virginia and Dr. Richard D. Smith at Pacific Northwest National Laboratory (PNNL), respectively. Feng received US HUPO Career Development Award in Technologies, San Francisco, CA, March 2012. and Great Manager Award, Leading through Change‚ in 2018 at PTD US, Genentech. She has in-depth knowledge and technical expertise in mass spectrometry and related methods for proteomics and antibody characterization (LC-MS, CE-MS, etc.), author of 58 (first author of 17) peer-reviewed publications and 1 book chapter (first author), corresponding author of PNAS and Anal. Chem. publications. Currently she is the assistant editor for mAbs journal.

Feng is currently both a technical and a people leader, and principal scientist at Genentech. She enjoys developing and advocating for talents she has interacted with. She has lean agility mindset through many roles as technical expert, analytical team leader, leading the MS functional excellence core, building a global MS community across Pharma Technical Development (PTD) at Roche, coach and as leadership team member at Protein Analytical Chemistry department, Genentech.  

LinkedIn: https://www.linkedin.com/in/feng-yang-2871b316/

Career Shorts Ep 4: [Release date 8th November 2021]

  • Home
  • Privacy & Terms of Use
  • About
  • Board of Directors
  • Advisors
  • Sponsors & Partners
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals